The  8th course is scheduled October 19-27, 2024

Director

Scientific advisors

Patrice Courvalin

Patrice Courvalin

Institut Pasteur, France
Heinz Moser_l

Heinz Moser

HEM consulting, USA
Michael Gilmore

Michael Gilmore

Harvard Medical School, USA

Scientific committee

Erin Duffy

Erin Duffy

CARB-X, USA
Jean-Francois Collet_s

Jean-Francois Collet

de Duve, Institute Belgium
Diarmaid Hugues

Diarmaid Hugues

Uppsala University, Sweden
François Lebreton

Francois Lebreton

Walter Reed Army Institute of Research, USA
Steven Lory

Steven Lory

Harvard Medical School, USA
Andrew Myers

Andrew Myers

Harvard University, USA
Steve Projan

Steve Projan

Beat the Reaper LLC, USA
Robin Patel_s

Robin Patel

Mayo Clinic, USA
John Rex

John Rex

F2G Ltd., UK
gerry_wright_s

Gerry Wright

McMaster University, Canada
Hans Georg Sahl

Hans Georg Sahl

University of Bonn, Germany
Man-Wah Tan

Man-Wah Tan

Genentech / Roche, USA
Ursula Theuretzbacher

Ursula Theuretzbacher

Center for Anti-Infective Agents, Vienna, Austria

Organising committee

Catherine Grillot-Courvalin

Catherine Grillot-Courvalin

Institut Pasteur, France
Benedicte Pansier

Bénédicte Pansier

Fondation Mérieux, France

Core faculty 2023

J. Ambler, ContraFect, USA,
D. Andes, University of Wisconsin, USA,
T. Bachmann, Edinburgh Med. School, UK,
S. Brisse, Institut Pasteur, France,
R. Brosch, Institut Pasteur, France,
E. Brown, McMaster University, Canada,
M. Brown, Flinders University, Australia,
R. Canton, Hospital Ramon y Cajal, Spain,
G. Challis, University of Warwick, UK,
J.-P. Charrier, bioMerieux, France,
J.-F. Collet, Université de Louvain, Belgium,
P. Courvalin, Institut Pasteur, France,
J.-D. Docquier, University of Siena, Italy,
R. Ebright, Rutgers University, USA,
M. Fisher, St Georges University, UK
M. Gilmore, Harvard Medical School, USA,
Y. Grad, Harvard Medical School, USA,
L. Hall-Stoodley, Ohio State University, USA,
S. Harbarth, Hopitaux de Genève, Switzerland,
S. Helaine, Harvard Medical School, USA,

 

 

D. Hughes, Uppsala University, Sweden,
F. Lebreton, Army Institute of Resarch, USA,
M. Lemonnier, Antabio, France,
S. Lory, Harvard Medical School, USA,
A. Mankin, University of Illinois, USA,
H. Moser, Novartis, USA,
A. Myers, Harvard University, USA,
S. Nambiar, Johnson & Johnson, USA,
R. Patel, Mayo Clinic, USA,
M. Pinho, Universidad Nova de Lisboa, Portugal,
S. Projan, Beat the Reaper, USA,
J. Rex, F2G, UK,
H.-G. Sahl, University of Bonn, Germany,
W. Shafer, Emory University, US,
P. Stoodley, Ohio State University, USA,
I. Stzepourginski, Eligo-bioscience, France,
M.-W. Tan, Genentech/Roche, USA
U. Theuretzbacher, CEFAIA, Austria,
P. Turner, Yale University, USA,
N. Vàzquez-Laslop, University of Illinois, USA,
G. Wright, McMaster University, Canada

Scroll to Top